Literature DB >> 23836888

CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.

Erik T Dustrude1, Sarah M Wilson, Weina Ju, Yucheng Xiao, Rajesh Khanna.   

Abstract

Voltage-gated sodium channel (NaV) trafficking is incompletely understood. Post-translational modifications of NaVs and/or auxiliary subunits and protein-protein interactions have been posited as NaV-trafficking mechanisms. Here, we tested if modification of the axonal collapsin response mediator protein 2 (CRMP2) by a small ubiquitin-like modifier (SUMO) could affect NaV trafficking; CRMP2 alters the extent of NaV slow inactivation conferred by the anti-epileptic (R)-lacosamide, implying NaV-CRMP2 functional coupling. Expression of a CRMP2 SUMOylation-incompetent mutant (CRMP2-K374A) in neuronal model catecholamine A differentiated (CAD) cells did not alter lacosamide-induced NaV slow inactivation compared with CAD cells expressing wild type CRMP2. Like wild type CRMP2, CRMP2-K374A expressed robustly in CAD cells. Neurite outgrowth, a canonical CRMP2 function, was moderately reduced by the mutation but was still significantly higher than enhanced GFP-transfected cortical neurons. Notably, huwentoxin-IV-sensitive NaV1.7 currents, which predominate in CAD cells, were significantly reduced in CAD cells expressing CRMP2-K374A. Increasing deSUMOylation with sentrin/SUMO-specific protease SENP1 or SENP2 in wild type CRMP2-expressing CAD cells decreased NaV1.7 currents. Consistent with a reduction in current density, biotinylation revealed a significant reduction in surface NaV1.7 levels in CAD cells expressing CRMP2-K374A; surface NaV1.7 expression was also decreased by SENP1 + SENP2 overexpression. Currents in HEK293 cells stably expressing NaV1.7 were reduced by CRMP2-K374A in a manner dependent on the E2-conjugating enzyme Ubc9. No decrement in current density was observed in HEK293 cells co-expressing CRMP2-K374A and NaV1.1 or NaV1.3. Diminution of sodium currents, largely NaV1.7, was recapitulated in sensory neurons expressing CRMP2-K374A. Our study elucidates a novel regulatory mechanism that utilizes CRMP2 SUMOylation to choreograph NaV1.7 trafficking.

Entities:  

Keywords:  CRMP2; NaV1.1; NaV1.7; Patch Clamp Electrophysiology; Post-translational Modification; Signaling; Sodium Channels; Sumoylation; Trafficking

Mesh:

Substances:

Year:  2013        PMID: 23836888      PMCID: PMC3750134          DOI: 10.1074/jbc.M113.474924

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  The structure of human collapsin response mediator protein 2, a regulator of axonal growth.

Authors:  Pål Stenmark; Derek Ogg; Susanne Flodin; Alex Flores; Tetyana Kotenyova; Tomas Nyman; Pär Nordlund; Petri Kursula
Journal:  J Neurochem       Date:  2007-01-22       Impact factor: 5.372

Review 2.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

3.  CRMP-2 induces axons in cultured hippocampal neurons.

Authors:  N Inagaki; K Chihara; N Arimura; C Ménager; Y Kawano; N Matsuo; T Nishimura; M Amano; K Kaibuchi
Journal:  Nat Neurosci       Date:  2001-08       Impact factor: 24.884

4.  Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.

Authors:  Joel M Brittain; Yuying Wang; Omotore Eruvwetere; Rajesh Khanna
Journal:  FEBS Lett       Date:  2012-09-26       Impact factor: 4.124

5.  Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels.

Authors:  Yuying Wang; Ki Duk Park; Christophe Salome; Sarah M Wilson; James P Stables; Rihe Liu; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2011-02-16       Impact factor: 4.418

6.  One SUMO is sufficient to silence the dimeric potassium channel K2P1.

Authors:  Leigh D Plant; Irina S Dementieva; Astrid Kollewe; Sonia Olikara; Jeremy D Marks; Steve A N Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

7.  Analysis of SUMO-1 modification of neuronal proteins containing consensus SUMOylation motifs.

Authors:  Kevin A Wilkinson; Atsushi Nishimune; Jeremy M Henley
Journal:  Neurosci Lett       Date:  2008-03-15       Impact factor: 3.046

8.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

9.  SUMO modification of cell surface Kv2.1 potassium channels regulates the activity of rat hippocampal neurons.

Authors:  Leigh D Plant; Evan J Dowdell; Irina S Dementieva; Jeremy D Marks; Steve A N Goldstein
Journal:  J Gen Physiol       Date:  2011-05       Impact factor: 4.086

Review 10.  Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction.

Authors:  Stéphane Martin; Kevin A Wilkinson; Atsushi Nishimune; Jeremy M Henley
Journal:  Nat Rev Neurosci       Date:  2007-12       Impact factor: 34.870

View more
  44 in total

1.  Modulator-Gated, SUMOylation-Mediated, Activity-Dependent Regulation of Ionic Current Densities Contributes to Short-Term Activity Homeostasis.

Authors:  Anna R Parker; Lori A Forster; Deborah J Baro
Journal:  J Neurosci       Date:  2018-11-30       Impact factor: 6.167

2.  CRMP2-Neurofibromin Interface Drives NF1-related Pain.

Authors:  Aubin Moutal; Li Sun; Xiaofang Yang; Wennan Li; Song Cai; Shizhen Luo; Rajesh Khanna
Journal:  Neuroscience       Date:  2018-04-12       Impact factor: 3.590

Review 3.  The physiological function of different voltage-gated sodium channels in pain.

Authors:  George Goodwin; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2021-03-29       Impact factor: 34.870

4.  CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.

Authors:  Aubin Moutal; Lex Salas Villa; Seul Ki Yeon; Kyle T Householder; Ki Duk Park; Rachael W Sirianni; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2017-06-28       Impact factor: 5.590

5.  Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Authors:  Jie Yu; Aubin Moutal; Angie Dorame; Shreya S Bellampalli; Aude Chefdeville; Iori Kanazawa; Nancy Y N Pham; Ki Duk Park; Jill M Weimer; Rajesh Khanna
Journal:  Mol Neurobiol       Date:  2018-12-18       Impact factor: 5.590

6.  AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain.

Authors:  Hongwei Yu; Seung Min Shin; Hongfei Xiang; Dongman Chao; Yongsong Cai; Hao Xu; Rajesh Khanna; Bin Pan; Quinn H Hogan
Journal:  Gene Ther       Date:  2019-05-22       Impact factor: 5.250

7.  A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.

Authors:  Erik Thomas Dustrude; Samantha Perez-Miller; Liberty François-Moutal; Aubin Moutal; May Khanna; Rajesh Khanna
Journal:  Channels (Austin)       Date:  2017-02-28       Impact factor: 2.581

8.  Blocking CRMP2 SUMOylation reverses neuropathic pain.

Authors:  A Moutal; E T Dustrude; T M Largent-Milnes; T W Vanderah; M Khanna; R Khanna
Journal:  Mol Psychiatry       Date:  2018-11       Impact factor: 15.992

Review 9.  Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

Authors:  Lindsey A Chew; Shreya S Bellampalli; Erik T Dustrude; Rajesh Khanna
Journal:  Biochem Pharmacol       Date:  2019-01-27       Impact factor: 5.858

10.  Hierarchical CRMP2 posttranslational modifications control NaV1.7 function.

Authors:  Erik T Dustrude; Aubin Moutal; Xiaofang Yang; Yuying Wang; May Khanna; Rajesh Khanna
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.